UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038313
Receipt number R000043639
Scientific Title Effect of intradialytic exercise in hemodialysis patients
Date of disclosure of the study information 2019/11/01
Last modified on 2021/04/17 10:07:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of intradialytic exercise in hemodialysis patients

Acronym

Effect of intradialytic exercise in hemodialysis patients

Scientific Title

Effect of intradialytic exercise in hemodialysis patients

Scientific Title:Acronym

Effect of intradialytic exercise in hemodialysis patients

Region

Japan


Condition

Condition

End stage kidney disease

Classification by specialty

Nephrology Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We assess potential factors which affect the effect of intradialytic exercise for sarcopenia.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Muscle mass, muscle strength, and physical performance six months after the initiation of intradialytic exercise

Key secondary outcomes

Index of depression, frailty index and nutritional data six months after the initiation of intradialytic exercise


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Intradialytic exercise
Resistance training and aerobic exercise

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Hemodialysis patients

Key exclusion criteria

Patients with severe cardiovascular disease

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Takizawa

Organization

Teine Keijinkai Hospital

Division name

Devision of nephrology

Zip code

006-0811

Address

1-12, Maeda, Teine-ku, Sapporo, Hokkaido, Japan

TEL

011-681-8111

Email

takizawa.tdr@keijinkai.or.jp


Public contact

Name of contact person

1st name Takuto
Middle name
Last name Maeda

Organization

Teine Keijinkai Hospital

Division name

Devision of nephrology

Zip code

006-0811

Address

1-12, Maeda, Teine-ku, Sapporo, Hokkaido, Japan

TEL

011-681-8111

Homepage URL


Email

maeda-ta@keijinkai.or.jp


Sponsor or person

Institute

Teine keijinkai hospital

Institute

Department

Personal name



Funding Source

Organization

No

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teine keijinkai hospital

Address

1-12, Maeda, Teine-ku, Sapporo, Hokkaido, Japan

Tel

011-681-8111

Email

teine@keijinkai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 10 Month 01 Day

Date of IRB

2019 Year 10 Month 10 Day

Anticipated trial start date

2019 Year 11 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 10 Month 16 Day

Last modified on

2021 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043639


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name